Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$44.6K Hold
347
0.02% 79
2026
Q1
$41.7K Hold
347
0.02% 78
2025
Q4
$36.5K Sell
347
-973
-74% -$91.3K 0.02% 86
2025
Q3
$111K Hold
1,320
0.06% 65
2025
Q2
$104K Hold
1,320
0.06% 66
2025
Q1
$118K Hold
1,320
0.07% 62
2024
Q4
$131K Hold
1,320
0.08% 61
2024
Q3
$150K Sell
1,320
-1,036
-44% -$123K 0.08% 60
2024
Q2
$292K Buy
2,356
+1,036
+78% +$133K 0.19% 43
2024
Q1
$155K Sell
1,320
-1,036
-44% -$128K 0.09% 59
2023
Q4
$257K Hold
2,356
0.17% 49
2023
Q3
$243K Buy
2,356
+279
+13% +$30.1K 0.17% 47
2023
Q2
$240K Sell
2,077
-5,560
-73% -$631K 0.16% 49
2023
Q1
$882K Buy
7,637
+5,560
+268% +$600K 0.54% 25
2022
Q4
$229K Buy
+2,077
New +$212K 0.18% 39

Other funds holding MRK

Granite FO LLC's MRK Position: Q2 2026 in Review

Granite FO LLC held its Merck (MRK) position steady in Q2 2026 at 347 shares worth $44.6K. The position accounts for 0.02% of the portfolio, ranked #79.

Granite FO LLC first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. The position peaked at $882K in Q1 2023. 1,876 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Granite FO LLC held 347 shares of Merck worth $44.6K as of Q2 2026.
  • Granite FO LLC left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.02% of Granite FO LLC's portfolio in Q2 2026, its #79 holding.
  • Granite FO LLC first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
  • Granite FO LLC's Merck position peaked at $882K in Q1 2023.
  • 1,876 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Granite FO LLC's 13F filing for Q2 2026, filed 15 Jul 2026.